24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
FDA
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:43
Full list of Israeli high-tech layoffs in 2025
13:38
Hydrogen startup Electriq Global collapses under nearly $30M in debt, despite raising $25M
11:26
PwC integrates altshare’s algorithm to streamline startup valuations
14:27
Nice beats Q4 estimates but shares plunge on weak 2025 outlook
More stories
Buzz
Most popular
Daily
Weekly
1
Insight Partners hit by cyber attack with possible data leaks
2
CyberArk’s surge, Wiz and Cato prepare for IPOs: Israeli cyber firms ready for the next big move
3
How Intel ruined an Israeli startup it bought for $2B—and lost the AI race
4
Riskified cuts staff as struggles continue
5
Techtonic to invest over $140 million to build one of Israel's largest data centers
More news
FDA
16 stories about FDA
Teva Wins FDA Approval for First Generic EpiPen
19.08.18
|
Lilach Baumer
EpiPens were sold for less than $60 when Mylan acquired the injectors in 2007. Market Monopoly enabled the company to hike its price up to around $300 a unit today
Medical Analytics Company DiA Imaging Raises $5 Million
08.08.18
|
CTech
DiA develops a medical imaging analysis software based on pattern recognition and machine learning algorithms
Mobile Phone Urine Testing Kit Receives FDA Approval
26.07.18
|
Tofi Stoler
Developed by Tel Aviv-based Healthy.io, the technology uses computer vision algorithms, artificial intelligence, and a smartphone’s built-in camera to run lab-standard urine tests
Kleiner Perkins, Alphabet Back Stroke Detection Startup Viz.ai
18.07.18
|
Meir Orbach
Kleiner Perkins led a $21 million round for the medical startup. Viz.ai develops an automated analysis of brain scans
Following FDA Clearance, BioSight to Launch Clinical Trial for Treatment of Leukemia
15.07.18
|
CTech
The company’s compound will be administered to patients unfit for standard chemotherapy
Sustained Drug Release Company UroGen Submits New Drug Application to FDA
12.07.18
|
Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
MediWound’s Pineapple-Based Burn Treatment to Treat Mustard Gas Burns
31.05.18
|
Dror Reich
The Nasdaq-listed, Israeli based company received the FDA’s approval to expand the use of flagship burn treatment NexoBrid to those suffering from Sulfur Mustard injuries
CTech's Tuesday Roundup of Israeli Tech News
24.04.18
|
CTech
The challenges of living on Mars: air, water, lack of personal space. Israeli lawmaker’s Twitter account suspended after tweet saying Palestinian girl in custody should have been shot
AI Healthcare Company Viz.ai Receives FDA Clearance for Stroke Detection Technology
23.04.18
|
Hagar Ravet
Viz.ai develops deep learning and AI-powered technology that can analyze brain scans and automatically transfer pertinent data to a physician to ensure the most immediate treatment for strokes
ReWalk Launches Clinical Trials for Robotic Physical Rehab Suit
04.04.18
|
Asaf Shalev
After the conclusion of the 40-person trial, the company will seek clearance from U.S. and European regulators
Israeli Telehealth Startup Tyto Care Raises $21 Million
28.01.18
|
Meir Orbach
Tyto Care develops a digital stethoscope for remote medical testing and diagnosis
Kite Pharma’s Cancer Drug Gets Regulatory Nod
19.10.17
|
Lilach Baumer
The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000
Teva Submits Potential Moneymaker Migraine Drug for FDA Approval
18.10.17
|
Dror Reich and Lilach Baumer
Teva’s patent for its moneymaker multiple sclerosis drug Copaxone expired last year
Teva’s Stock Drops After Approval of Copaxone Competitors
08.10.17
|
Lilach Baumer
A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug
Teva Loses Copaxone Market Exclusivity
04.10.17
|
Lilach Baumer
Rival Mylan received FDA approval for its generic versions of Copaxone, Teva’s flagship drug
Developer Of Anti-Rabies Drug Jumps on FDA Approval
27.08.17
|
Dror Reich
The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus
Previous Articles
